Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
News (4)
387 Articles Available
4
17
Can't find what you're looking for? Try our
advanced search
.
Strategic Partnership
AstraZeneca Launches Strategic Joint Venture in China
PAO-M12-17-NI-005
Clinical Trial
Zika Vaccine Candidate Enters Phase I Trial
PAO-M12-17-NI-008
Strategic Partnership
Russia’s BIOCAD to Manufacture Biosimilars in North Africa
PAO-M12-17-NI-007
Cell and Gene Therapy
Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts
PAO-M12-17-NI-006
Drug Development
Thermo Fisher Scientific’s Patheon Division to Manufacture Nasal Formulation for Evoke Pharma
PAO-M12-17-NI-003
Strategic Partnership
New Collaboration Targets the Development of Oligonucleotides
PAO-M12-17-NI-002
PAO-M12-17-NI-001
Amerisource Bergen Expands in the US with Acquisition of H.D. Smith
PAO-M12-17-NI-001
Acquisition
Pharmaterials Acquired by Quotient Sciences
PAO-M11-17-NI-051
Research
Study Finds Less Teflon in Environment Leads to Less Brain Damage
PAO-M11-17-NI-052
Innovation
Single-Pill, HIV-1 Combination Therapy Approved
PAO-M11-17-NI-050
Discovery
Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration
PAO-M11-17-NI-049
FDA Approval
Advanced Follicular Lymphoma Treatment Approved
PAO-M11-17-NI-048
Expansion
Fresenius Kabi Plans $100 Million North Carolina Expansion
PAO-M11-17-NI-047
Biosimilars
Boehringer Ingelheim’s Adalimumab Biosimilar Wins First EU Approval
PAO-M11-17-NI-045
Gene Editing
Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
PAO-M11-17-NI-046
Adherence
Digital Technology Makes It into Medicines
PAO-M11-17-NI-044
Gene Editing
More Gene Editing Technology Being Developed by Novartis
PAO-M11-17-NI-043
Partnership
Alcami to Produce Clinical Supplies of Darinaparsin for Solasia
PAO-M11-17-NI-042
Nanopharmaceuticals
Glycan-coated Gold Nanoparticles are Target of Nanofacturing Consortium
PAO-M11-17-NI-041
Innovation
Study Reveals New Medication Options for Opioid Dependency
PAO-M11-17-NI-040
BioRobotics
Bioengineered Robotic Hand Senses Touch
PAO-M11-17-NI-039
FDA Approval
AstraZeneca’s Anti-Asthma FASENRA Wins FDA Approval
PAO-M11-17-NI-038
Innovation
Artificial Intelligence Powers New PAD Blood Test
PAO-M11-17-NI-037
Non-Opioid
SiteOne Therapeutics Garners US Department of Defense Award
PAO-M11-17-NI-036
«
4
17
»
.svg)
